Modulation of CRMP2 via ( S )-Lacosamide Shows Therapeutic Promise but Is Ultimately Ineffective in a Mouse Model of CLN6-Batten Disease

Neuronal Signaling
doi 10.1042/ns20190001
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Portland Press Ltd.

Related search

Tracking Sex-Dependent Differences in a Mouse Model of CLN6-Batten Disease

Orphanet Journal of Rare Diseases
MedicineGeneticsPharmacology
2019English

Searching for Novel Biomarkers Using a Mouse Model of CLN3-Batten Disease

PLoS ONE
Multidisciplinary
2018English

Bortezomib Is Ineffective in an Orthotopic Mouse Model of Pancreatic Adenocarcinoma

Molecular Cancer Therapeutics
Cancer ResearchOncology
2008English

Therapeutic Modulation of Cerebral Microhemorrhage in a Mouse Model of Cerebral Amyloid Angiopathy

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2011English

The Therapeutic Promise of Positive Allosteric Modulation of Nicotinic Receptors

European Journal of Pharmacology
Pharmacology
2014English

389 Therapeutic Implication of IL-15Rα in Behçet’s Disease Mouse Model

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2017English

Comparative Therapeutic Effects of Velaglucerase Alfa and Imiglucerase in a Gaucher Disease Mouse Model

PLoS ONE
Multidisciplinary
2010English

Attenuation of Microglial Activation in a Mouse Model of Alzheimer’s Disease via NFAT Inhibition

Journal of Neuroinflammation
Molecular NeuroscienceNeurologyImmunologyCellularNeuroscience
2015English

Therapeutic Effects of Mouse Bone Marrow-Derived Clonal Mesenchymal Stem Cells in a Mouse Model of Inflammatory Bowel Disease

Journal of Clinical Biochemistry and Nutrition
MedicineNutritionClinical BiochemistryDietetics
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy